Search results
Decoding Gilead Sciences Inc (GILD): A Strategic SWOT Insight
Guru Focus· 57 minutes agoOn May 8, 2024, Gilead Sciences Inc (GILD, Financial), a leading biopharmaceutical company, filed its 10-Q report with the SEC, providing a detailed account ...
Gilead Helps Put African Nation on Path To Eliminate
3BL CSRwire· 17 hours agoJames had been free from using drugs for a decade when a routine test at his local health center revealed he had hepatitis C (HCV). James was one of many people in the island nation of Mauritius ...
Choreo LLC Raises Stock Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)
ETF DAILY NEWS· 7 days agoChoreo LLC increased its stake in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 53.6% in the fourth quarter, according to its most recent ...
Understanding the Risks of Investing in Kyverna Therapeutics Inc.
Knox Daily· 1 day agoKyverna Therapeutics Inc.’s recent filing unveils that its 10% Owner GILEAD SCIENCES, INC. acquired Company’s shares for reported $20.02 million on Feb ...
Gilead Sciences Unusual Options Activity For May 06 - Gilead Sciences (NASDAQ:GILD)
Benzinga· 3 days agoLoading... Loading... Financial giants have made a conspicuous bearish move on Gilead Sciences. Our analysis of options history for Gilead</ ...
The Zacks Analyst Blog Highlights Gilead Sciences, GSK, Deciphera, Bristol Myers and Editas Medicine
Zacks via Yahoo Finance· 6 days agoEvery day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and...
Forbes Has Listed Gilead as One of America’s Best
3BL CSRwire· 3 days agoForbes has listed Gilead as one of America’s Best Employers for Diversity. Gilead Sciences, Inc. is a research-based biopharmaceutical company that...
Gilead Sciences, Inc. [NASDAQ: GILD] Sees Decrease in Stock Value – Knox Daily
Knox Daily· 6 days agoInvestors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Gilead Sciences, Inc. shares valued at $368,790 were ...
Gilead cuts jobs, trims drugs amid deeper biopharma pullback - San Francisco Business Times
The Business Journals· 6 days agoGilead Sciences Inc. will cut 58 jobs at its Foster City campus after writing off $2.4 billion for a cancer drug that was the cornerstone of a $21 billion ...
Gilead Sciences, Inc. (GILD): Be Patient, You Will Learn – Stocks Register
Stocks Register· 6 days agoGilead Sciences, Inc. (NASDAQ:GILD) at last check was buoying at $64.49 on Friday, May 03, with a fall of -1.29% from its closing price on previous day.
